Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report

BACKGROUND: The treatment of advanced or metastatic renal cell carcinoma (RCC) has drastically changed since the approval of immune checkpoint therapy. Nivolumab is a treatment option for patients with metastatic RCC, previously treated with targeted antiangiogenic therapy. The efficacy of nivolumab...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Urol
Main Authors: Noguchi, Go, Tsutsumi, Sohgo, Yasui, Masato, Ohtake, Shinji, Umemoto, Susumu, Nakaigawa, Noboru, Yao, Masahiro, Kishida, Takeshi
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5907256/
https://ncbi.nlm.nih.gov/pubmed/29669553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-018-0339-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares